New Stock News | Shanghai Longqi Plans to List in Hong Kong IPO, China Securities Regulatory Commission Requires Explanation of the Actual Operation of Medical Instrument Business, etc.

On September 5th, the China Securities Regulatory Commission announced the disclosure of supplementary materials for overseas issuance and listing filing requirements (August 29, 2025 - September 4, 2025). The commission required Shanghai Longqi to supplement the information on the actual operation of the first, second, and third categories of medical device production, the first and second categories of medical device sales, and the third category of medical device operation included in the company and its subsidiaries' business scope, whether they have obtained the corresponding qualifications, and whether they are involved in the areas listed in the "Special Management Measures for Foreign Investment Access (Negative List) (2024 version)". They also requested information on whether the operating scope of the company's subsidiaries is involved in the areas listed in the "Special Management Measures for Foreign Investment Access (Negative List) (2024 version)". On June 27th, Shanghai Longqi submitted the application to the Hong Kong Stock Exchange, with Citigroup, Haitong International, and Guotai Junan International as joint sponsors. According to the prospectus, Shanghai Longqi is a leading global provider of smart products and services, offering comprehensive solutions for globally renowned smart product brands and leading technology companies, including product research, design, manufacturing, and support. The company currently has a diversified product portfolio covering smart phones, AI PCs, automotive electronics, tablets, smart watches/wristbands, and smart glasses, with core customers including Xiaomi, Samsung Electronics, Lenovo, Honor, OPPO, vivo, and other leading brands.